Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof

PH12022551022B1Active Publication Date: 2026-08-05MEDIMMUNE LTD

0 Cites 0 Cited by

Patent Information

Application Number: PH12022551022
Authority / Receiving Office: PH · PH
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-04-27
Publication Date: 2026-08-05
Estimated Expiration: 2042-04-27

Application Information

Patent Timeline

27 Apr 2022

Application

PH12022551022

05 Aug 2026

Publication

PH12022551022B1

Inventors: HUNTINGTON, Catherine, Eugenie, Chaillan; HOE, Susan

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present technology relates generally to dry powder formulations of antibodies specific for thymic stromal lymphopoietin (TSLP), as well as methods of treating asthma, using the dry powder formulations, suitably via pulmonary delivery.

Need to check novelty before this filing date? Find Prior Art